A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.
Completed · Phase 2 · Has a placebo group
Conditions studied: Respiratory Syncytial Virus Infections
In brief
The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and antidrug antibody (ADA) response for MEDI8897 in healthy preterm infants who are between 29 and 35 weeks gestational age (GA) and entering their first Respiratory Syncytial Virus (RSV) season.
Key facts
- Study ID
- NCT02878330
- Run by
- MedImmune LLC
- People needed
- 1453
- Starts
- 2016-11-03
- Expected to finish
- 2018-12-06
- Last updated by the study team
- 2019-10-14
Who can join
Age: any, up to 1. Sex: any. Healthy volunteers: accepted.
Where it is running
- Research Site — Anaheim, California, United States
- Research Site — Anaheim, California, United States
- Research Site — Downey, California, United States
- Research Site — Long Beach, California, United States
- Research Site — Los Angeles, California, United States
- Research Site — Paramount, California, United States
- Research Site — San Diego, California, United States
- Research Site — West Covina, California, United States
- Research Site — Aurora, Colorado, United States
- Research Site — Colorado Springs, Colorado, United States
- Research Site — Hartford, Connecticut, United States
- Research Site — Gainesville, Florida, United States
- Research Site — Orlando, Florida, United States
- Research Site — South Miami, Florida, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Augusta, Georgia, United States
- Research Site — Chicago, Illinois, United States
- Research Site — Oak Lawn, Illinois, United States
- Research Site — Park Ridge, Illinois, United States
- Research Site — South Bend, Indiana, United States
- Research Site — Woburn, Massachusetts, United States
- Research Site — Detroit, Michigan, United States
- Research Site — Jackson, Mississippi, United States
- Research Site — Columbia, Missouri, United States
- Research Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.